NBC Securities’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.3K Hold
100
﹤0.01% 1923
2026
Q1
$8.89K Hold
100
﹤0.01% 1962
2025
Q4
$9.52K Hold
100
﹤0.01% 2036
2025
Q3
$9.86K Hold
100
﹤0.01% 2015
2025
Q2
$10K Hold
100
﹤0.01% 1937
2025
Q1
$9K Buy
+100
New +$11.2K ﹤0.01% 1744
2024
Q4
Sell
-107
Closed -$12K 1356
2024
Q3
$12K Buy
107
+7
+7% +$644 ﹤0.01% 1669
2024
Q2
$8K Hold
100
﹤0.01% 1739
2024
Q1
$9K Buy
100
+52
+108% +$4.99K ﹤0.01% 1722
2023
Q4
$5K Buy
48
+33
+220% +$3.33K ﹤0.01% 1858
2023
Q3
$1K Buy
+15
New +$1.66K ﹤0.01% 2053

Other funds holding BNTX

NBC Securities's BNTX Position: Q2 2026 in Review

NBC Securities held its BioNTech (BNTX) position steady in Q2 2026 at 100 shares worth $9.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

NBC Securities first reported a position in BNTX in Q3 2023 and has held it in 11 quarters since. The position peaked at $12K in Q3 2024. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • NBC Securities held 100 shares of BioNTech worth $9.3K as of Q2 2026.
  • NBC Securities left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1923 holding.
  • NBC Securities first reported a position in BioNTech in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's BioNTech position peaked at $12K in Q3 2024.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.